Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

admin.veranex : Mar 24, 2025 10:22:49 PM

Commercial Strategy & Market Access

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey. Hypothetical patient profiles created using clinical parameters demonstrated the clinical utility of a novel kidney diagnostic used to risk-stratify patients based on the risk of kidney function decline.

Read the Article

Study by Veranex and Proteomics International Demonstrates Clinical Utility of Prognostic Test for Type 2 Diabetes Patients

admin.veranex : Mar 24, 2025 10:23:07 PM

By conducting a clinical utility study for Proteomics International’s PromarkerD (a blood-based test that predicts the risk of kidney...

Commercial Strategy & Market Access
Read More

Leveraging Medtech Innovation in Clinical Trials

admin.veranex : Mar 24, 2025 10:23:11 PM

Rebecca Ford, Director of Program Management, discusses how to Leverage medical technology and innovation in clinical trials to drive medication...

Read More

The Power of Generative Artificial Intelligence in Medical Writing

Yurii Kartashov : Mar 24, 2025 10:22:47 PM

The use of artificial intelligence (AI) in clinical trials is evolving quickly. According to the research and consulting firm, Gartner, the life...

Read More